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We quantify the amount of regulation required to control growth in living cells by a Maximum Entropy
approach to the space of underlying metabolic states described by genome-scale models. Results obtained for E.
coli and human cells are consistent with experiments and point to different regulatory strategies by which growth
can be fostered or repressed. Moreover we explicitly connect the ‘inverse temperature’ that controls MaxEnt
distributions to the growth dynamics, showing that the initial size of a colony may be crucial in determining
how an exponentially growing population organizes the phenotypic space.
To a great extent, the physiologic state of a living cell is
determined by how a large number of “microscopic” degrees
of freedom subject to noise (nutrient import rates, metabolic
reaction fluxes, gene expression levels, etc.) coordinate in re-
sponse to the sensing of the extracellular conditions. This pro-
cess ultimately correlates different regulatory variables and
constrains the cell to a portion of the space of their physico-
chemically viable configurations. In turn, the amount by
which the accessible volume of the feasible space is reduced
(or the entropy change) can be thought to quantify, roughly
speaking, the overall amount of regulation required to cor-
rectly modulate the cell’s physiology. A key idea in such a
scenario is that the desired fitness level and the strength of reg-
ulation necessary to achieve it are tightly linked [1, 2]. Having
access to detailed information on genetic and metabolic vari-
ables one may now hope to characterize the set of phenotypes
selected by regulation in terms of the behaviour of individual
degrees of freedom. On the other hand, a principle-based ap-
proach might provide meaningful system-level insights. An
important question in this respect is the following: is it pos-
sible to describe the selected region of the feasible space in
physically precise terms?
Bacteria, whose physiology is primarily described by their
growth rate, may yield important clues. Experiments prob-
ing bacterial growth at single-cell resolution can in fact ap-
praise the significant cell-to-cell variability that accompanies
the establishment of a well-defined mean growth rate across
an exponentially growing population [3–5]. Such a hetero-
geneity reflects the underlying phenotypes at a macroscopic
level and may therefore carry strong regulatory signatures.
Single-cell growth rate distributions measured for E. coli have
indeed been shown to correspond to maximum entropy (Max-
Ent) distributions of its viable metabolic flux patterns at fixed
mean growth rate, suggesting that metabolic regulation real-
izes a tradeoff between the high fitness of fast-growing states
and the high density of slow-growing ones [6].
By shifting the optimization target from the growth rate to
its entropic costs, the MaxEnt approach offers a view that is
compatible both with the presence of noise in gene expres-
sion, which poses fundamental limits to growth rate optimiza-
tion, and with the idea that the metabolic costs of strictly
optimizing growth in fluctuating environments may be pro-
hibitive. Here we show that the MaxEnt principle allows to
quantify the strength of regulation required to both foster and
repress growth from genome-scale models of metabolic net-
works, pointing to specific mechanisms that cells can exploit
to implement those strategies. In addition, we propose an in-
terpretation for the ‘inverse temperature’ parameter that con-
trols MaxEnt distributions by connecting it to a well known
population growth law.
We focus on metabolic degrees of freedom, denoting by
v = {vi} the fluxes of metabolic reactions (i = 1, . . . , N with
N the number of reactions) and by λ ≡ λ(v) the growth rate
corresponding to flux configuration v. The space F of fea-
sible flux vectors v is formed by the non-equilibrium steady
states of the underlying metabolic network, given by the solu-
tions of Sv = 0, where S denotes the M ×N stoichiometric
matrix (M being the number of chemical species) and a spe-
cific range of variability [vmini , v
max
i ] is prescribed for each vi
based on thermodynamic and kinetic constraints [7]. MaxEnt
distributions with prescribed mean growth rate 〈λ〉 over F are
given by [6]
p(v) =
eβλ(v)
Z(β)
(v ∈ F) , (1)
where Z(β) =
∫
eβλ(v)dv while β is the Lagrange mul-
tiplier enforcing the constraint 〈λ〉 = ∫ λ(v)p(v)dv. The
limit β → 0 (resp. β  1) describes a uniform distribution
of flux vectors (resp. a distribution that concentrates around
maxv λ(v) ≡ λmax). For each given β (or 〈λ〉), sampling
by (1) reduces the entropy of F with respect to the uniform
sampling with β = 0 by a factor 2I , with I given by [6]
I log 2 = β 〈λ〉 −
∫ β
0
〈λ〉 dβ′ , (2)
where 〈λ〉 is a function of β. The above quantity (measured in
bits) can be interpreted as the minimal amount of regulation
required to establish a given mean growth rate 〈λ〉. Clearly I
increases as cells are pushed to faster rates by increasing β.
The 〈λ〉 vs I curve obtained from (2) upon varying β there-
fore separates the (I, 〈λ〉) plane in a feasible region (where
I is large enough for the corresponding value of 〈λ〉) and a
forbidden region (where I is too small).
Figure 1A (main panel, black line) shows the structure ob-
tained by increasing β starting from 0 (blue marker) for E.
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FIG. 1. Main panels: (A) 〈λ〉 /λmax versus I trade-off curve com-
puted from E. coli’s iJR904 genome-scale metabolic network model
assuming a glucose-limited minimal medium (λmax = 1/h). The
blue, green and orange markers denote respectively the values of
〈λ〉 /λmax (i) found for β = 0 (i.e. for an unbiased sampling of the
feasible space), (ii) estimated for E. coli in the human gut (roughly
corresponding to a doubling time of 40 hours), and (iii) computed in
[6] for two sets of growth rate distributions, respectively described
by the values 〈λ〉 /λmax ' 0.28 and ' 0.45. (B) 〈λ〉 /λmax ver-
sus I trade-off curve computed from the human catabolic core net-
work with λmax ' 0.046/h, corresponding to a fast growth rate for
cancer cells (doubling time ' 15 hours). Blue and green markers
represent respectively the estimated renewal rates of various healthy
human tissues and the estimated growth rates of different types of
cancers. Insets: (A) β? versus log(K/N0) for the minimal model of
population growth described in the text (see Eq. (7)); (B) measured
doubling times of different cancer cell types as functions of the in-
oculum size N0. All data points were obtained from bionumbers.org
except for those in the inset of panel (B), which were obtained from
dtp.cancer.gov/discovery development/nci-60/cell list.htm.
coli growth in a minimal glucose-limited medium based on the
iJR904 genome-scale metabolic network model (N = 1075,
M = 761 [8]). Ref. [6] has shown that MaxEnt distributions
lying on this line reproduce different sets of empirical data by
fitting a single parameter, with the values of 〈λ〉 /λmax dis-
played by orange markers. The standard E. coli growth rate in
the human gut, corresponding to a doubling time of about 40
hours (green marker), instead appears to be close to the mean
growth rate obtained for a flat sampling of F with β = 0,
with both lying close to 1% of λmax. Such fitness values are
achievable at very small regulatory costs, i.e. for I ' 0. This
however implies that slower growth rates require some degree
of regulation. A ‘slow growth’ branch in the (I, 〈λ〉) diagram
can be obtained by simply computing (2) for β < 0. This
leads to the red curve in Fig. 1A (main panel) and, in turn, to
a second forbidden region at small I and small 〈λ〉.
It would be interesting to check whether cells explore the
slow branch of the phase diagram as they seem to do with
the fast branch. Perhaps unsurprisingly, though, few studies
probed bacteria at very slow growth [9]. In human cells, on
the other hand, growth is actively downregulated. Fig. 1B
displays the (〈λ〉 , I) phase structure obtained from the carbon
catabolic core metabolism of human cells [10] together with
the estimated growth rates of 61 cancer types (green mark-
ers) and the estimated renewal rates of 21 human tissues (blue
markers). The mean fitness obtained for β = 0 is close to sep-
arating the two data sets, suggesting that healthy tissues might
probe states close to the slow branch.
It is instructive to compare I to the dimension of F , equal,
in the case of E. coli presented in Fig. 1A, to 233. In order
to get close to λmax cells have to invest considerably more
than one bit per degree of freedom into regulation, in agree-
ment with the view that growth rate maximization entails a
finer and finer tuning of metabolic reactions (and higher reg-
ulatory costs). On the other hand, slowing growth below the
“unregulated” limit only seems to require a fraction of a bit
per degree of freedom. A careful look at solutions selected by
the MaxEnt rule upon varying β (which can be computed as
in [6]) sheds light on the regulatory pathways that cells mod-
ulate to adjust their fitness. Focusing on conditions for which
λmax ' 0.4/h (so as to avoid effects due to gene expression
costs that set in at faster rates [11]), we see (Fig. 2A) that the
flow through futile cycles anticorrelates with the mean growth
rate for β > 0while it is roughly constant for β < 0 (Fig. 2A),
implying that the reduction of chemical energy dissipation is
a major mechanism of growth maximization [6]. Likewise,
increasing β appears to select solutions for which CO2 is the
main carbon compound excreted (Fig. 2B), in agreement with
the fact that the oxidative phenotype should be the dominat-
ing one at the growth rates under consideration. No major
rearrangement of these pathways is observed for β < 0, as
the mean glucose intake also remains constant (Fig. 2A). This
is not surprising as growth suppression requires much weaker
regulation than growth optimization (Fig. 1A). Interestingly,
the only reaction that appears to be significantly modulated
along the ‘slow branch’ of the phase diagram is acetolactate
synthase (ACLS, Fig. 2A), a key enzyme for the biosynthesis
of branched-chain amino acids, which plausibly limits growth
and is downregulated upon decreasing β.
This analysis raises the question of whether the parameter
β, which varies from−∞ to +∞, can be seen in more precise
terms than simply as a ‘degree of optimization’. To get some
insight, we consider a generalization of the logistic growth
model defined in [12]. Consider a population of N0 cells (in-
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FIG. 2. Modulation of different regulatory variables with 〈λ〉 /λmax
for MaxEnt flux configurations of E. coli found under glucose-
limited (maximum uptake 4.4 mmol/gDW/h) aerobic conditions with
λmax ' 0.4/h. (A) Mean fluxes through acetolactate synthase
(ACLS), length-2 futile cycles and glucose import. (B) Fraction
of carbon excreted as CO2 (cyan) and as other carbon-compounds
(brown). All fluxes are normalized to the maximum glucose import
flux. β increases from −∞ to +∞ as 〈λ〉 /λmax grows. The blue
triangle marks the value of 〈λ〉 /λmax corresponding to β = 0.
dexed i) initially planted in a growth medium with finite car-
rying capacity K and assume that their growth rates λi are
sampled independently from a distribution q(λ) defined over
the feasible space F . If the number ni of cells with growth
rate λi evolves in time according to
n˙i
ni
= λi
(
1− N
K
)
, N(t) =
N0∑
i=1
ni(t) , (3)
one easily sees that ni(t) = eβ(t)λi with
β(t) = t− 1
K
∫ t
0
N(t′)dt′ . (4)
In turn, we can approximate N(t) as
N(t) ' N0Z(β(t)) , Z(β) =
∫
q(λ)eβλdλ , (5)
so that
β˙ = 1− N0
K
Z(β) . (6)
At stationarity, β settles to a value β? fixed by the condition
Z(β?) =
K
N0
, (7)
which determines the asymptotic ‘degree of optimization’
given q(λ), the carrying capacity K and the size of the inocu-
lum N0. The inset of Fig. 1A shows the solutions obtained
for q(λ) ∝ (1 − λ/λmax)a [6] as a function of log(K/N0).
One sees that β > 0 for K > N0 while it rapidly becomes
more and more negative when N0 > K. In other terms, the
asymptotic distribution is of the MaxEnt type, and concen-
trates on growth-suppressing states with β < 0 for sufficiently
‘stressed’ initial conditions.
Despite its crudeness, this setup hints at the drivers that
cause a population of cells to organize in the feasible space
with a specific value of β, providing in turn a dynamical jus-
tification of the MaxEnt scenario. In essence, it is the ex-
ponential character of the growth law that leads to MaxEnt
distributions. Interestingly, the size N0 of the inoculum plays
an important role in this process. Remarkably, the fact that
〈λ〉 decreases as N0 increases is consistent with the increase
of doubling times with N0 found for various cancers in vitro
(at least for small enough N0, see inset of Fig. 1B). Overall,
the MaxEnt approach that proved useful in other biological
contexts [13] appears to provide a key to connect growth reg-
ulation to the entropy of the space of metabolic states. Our
results also offer a simple physical interpretation of the pa-
rameter β. Experiments probing slow-growth regimes may
clarify if E. coli cells saturate the slow branch of in Fig. 1A
as they seem to do with the fast branch.
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